These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17172422)

  • 1. Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer.
    Wetherill YB; Hess-Wilson JK; Comstock CE; Shah SA; Buncher CR; Sallans L; Limbach PA; Schwemberger S; Babcock GF; Knudsen KE
    Mol Cancer Ther; 2006 Dec; 5(12):3181-90. PubMed ID: 17172422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells.
    Wetherill YB; Petre CE; Monk KR; Puga A; Knudsen KE
    Mol Cancer Ther; 2002 May; 1(7):515-24. PubMed ID: 12479269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.
    Hess-Wilson JK; Webb SL; Daly HK; Leung YK; Boldison J; Comstock CE; Sartor MA; Ho SM; Knudsen KE
    Environ Health Perspect; 2007 Nov; 115(11):1646-53. PubMed ID: 18007998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status.
    Wetherill YB; Fisher NL; Staubach A; Danielsen M; de Vere White RW; Knudsen KE
    Cancer Res; 2005 Jan; 65(1):54-65. PubMed ID: 15665279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways.
    Shah S; Hess-Wilson JK; Webb S; Daly H; Godoy-Tundidor S; Kim J; Boldison J; Daaka Y; Knudsen KE
    Mol Cancer Res; 2008 Sep; 6(9):1507-20. PubMed ID: 18819937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.
    McCarty MF; Hejazi J; Rastmanesh R
    Integr Cancer Ther; 2014 Sep; 13(5):386-95. PubMed ID: 24867960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth.
    Cha TL; Qiu L; Chen CT; Wen Y; Hung MC
    Cancer Res; 2005 Mar; 65(6):2287-95. PubMed ID: 15781642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer.
    Kaseb AO; Chinnakannu K; Chen D; Sivanandam A; Tejwani S; Menon M; Dou QP; Reddy GP
    Cancer Res; 2007 Aug; 67(16):7782-8. PubMed ID: 17699783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.
    Marques RB; Erkens-Schulze S; de Ridder CM; Hermans KG; Waltering K; Visakorpi T; Trapman J; Romijn JC; van Weerden WM; Jenster G
    Int J Cancer; 2005 Nov; 117(2):221-9. PubMed ID: 15900601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of Bisphenol A on androgen receptor antagonism.
    Huang X; Cang X; Liu J
    Toxicol In Vitro; 2019 Dec; 61():104621. PubMed ID: 31415812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells.
    Auvin S; Öztürk H; Abaci YT; Mautino G; Meyer-Losic F; Jollivet F; Bashir T; de Thé H; Sahin U
    Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31431473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P450-dependent enzymes as targets for prostate cancer therapy.
    De Coster R; Wouters W; Bruynseels J
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):133-43. PubMed ID: 8603034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex role of AR signaling after cytotoxic insult: implications for cell-cycle-based chemotherapeutics.
    Comstock CE; Knudsen KE
    Cell Cycle; 2007 Jun; 6(11):1307-13. PubMed ID: 17568191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oral exposure to safe dose of bisphenol A in association with high-fat diet stimulate the prostatic lesions in a rodent model for prostate cancer.
    Facina CH; Campos SGP; Gonçalves BF; Góes RM; Vilamaior PSL; Taboga SR
    Prostate; 2018 Feb; 78(2):152-163. PubMed ID: 29148069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo.
    Landriscina M; Bagalà C; Piscazzi A; Schinzari G; Quirino M; Fabiano A; Bianchetti S; Cassano A; Sica G; Barone C
    Prostate; 2009 May; 69(7):744-54. PubMed ID: 19152342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
    Kazui Y; Fujii S; Yamada A; Ishigami-Yuasa M; Kagechika H; Tanatani A
    Bioorg Med Chem; 2018 Oct; 26(18):5118-5127. PubMed ID: 30228001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral exposure to low-dose bisphenol A induces hyperplasia of dorsolateral prostate and upregulates EGFR expression in adult
    Wu S; Huang D; Su X; Yan H; Wu J; Sun Z
    Toxicol Ind Health; 2019 Oct; 35(10):647-659. PubMed ID: 31771501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
    Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.